Literature DB >> 11345227

Liposomal amphotericin B and surgery in the successful treatment of invasive pulmonary mucormycosis in a patient with acute T-lymphoblastic leukemia.

M Björkholm1, G Runarsson, F Celsing, M Kalin, B Petrini, P Engervall.   

Abstract

Pulmonary mucormycosis is a usually fatal opportunistic infection in immunocompromised patients. We describe the first case of an adult patient with hematological malignancy and profound neutropenia to survive a disseminated pulmonary Rhizomucor pusillus infection. Early diagnostic procedures combined with high doses of liposomal amphotericin B and surgical resection may have contributed to the successful outcome.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11345227     DOI: 10.1080/003655401300077469

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  5 in total

Review 1.  Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species.

Authors:  Marisa Z R Gomes; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

2.  Molecular identification of Rhizomucor pusillus as a cause of sinus-orbital zygomycosis in a patient with acute myelogenous leukemia.

Authors:  Peter C Iwen; Alison G Freifeld; Lynne Sigler; Stefano R Tarantolo
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

3.  Differentiation of Rhizomucor species on the basis of their different sensitivities to lovastatin.

Authors:  Gyöngyi Lukács; Tamás Papp; Ildikó Nyilasi; Erzsébet Nagy; Csaba Vágvölgyi
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

4.  Liposomal amphotericin B and surgery as successful therapy for pulmonary Lichtheimia corymbifera zygomycosis in a pediatric patient with acute promyelocytic leukemia on antifungal prophylaxis with posaconazole.

Authors:  Grazina Kleinotiene; Gintas Posiunas; Juozas Raistenskis; Edvardas Zurauskas; Sigita Stankeviciene; Valentina Daugelaviciene; Maciej Machaczka
Journal:  Med Oncol       Date:  2013-01-10       Impact factor: 3.064

5.  Pulmonary mucormycosis: A case report and review of the literature.

Authors:  Xi-Ming Wang; Ling-Chuan Guo; Sheng-Li Xue; Yan-Bin Chen
Journal:  Oncol Lett       Date:  2016-03-22       Impact factor: 2.967

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.